New NIBR President Jay Bradner shares on drug discovery, his leadership style and what’s next for his career in biomedical research.

The Chief Information Officer of the Novartis Institutes for BioMedical Research discusses his new role.

Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success

Three-dimensional clusters of human neurons could allow scientists to watch neurological diseases develop in the lab.

At Novartis, we are constantly pushing the limits of science to develop and deliver transformative medicines that fight disease and help people live life on their terms. 

A lung cancer researcher describes her journey toward a career in science at Novartis.

Radioligand therapy (RLT) has helped change what’s possible in prostate cancer treatment, but Novartis continues to work on the next wave of innovations to bring new options to patients.

A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.

Novartis researchers aim to improve the lives of patients with osteoarthritis.